Macquarie Group
NUTX

Macquarie Group’s Nutex Health NUTX Stock Holding History

Macquarie Group’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42K Buy
+246
New +$31.2K ﹤0.01% 858

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Macquarie Group's NUTX Position: Q2 2026 in Review

Macquarie Group opened a new position in Nutex Health (NUTX) in Q2 2026: 246 shares worth $42K. The stake represents ﹤0.01% of the portfolio and ranks #858 among its holdings.

154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Macquarie Group held 246 shares of Nutex Health worth $42K as of Q2 2026.
  • Nutex Health was a new Macquarie Group position in Q2 2026.
  • Nutex Health made up ﹤0.01% of Macquarie Group's portfolio in Q2 2026, its #858 holding.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Macquarie Group's 13F filing for Q2 2026, filed 14 Aug 2026.